Kousoulakou, H., Hatzikou, M., Baroutsou, V., & Yfantopoulos, J. (2017). Cost effectiveness of vildagliptin versus glimepiride as add-on treatment to metformin for the treatment of diabetes mellitus type 2 patients in Greece. Cost Eff Resour Alloc.
Citación estilo ChicagoKousoulakou, Hara, Magdalini Hatzikou, Varvara Baroutsou, and John Yfantopoulos. "Cost Effectiveness of Vildagliptin Versus Glimepiride As Add-on Treatment to Metformin for the Treatment of Diabetes Mellitus Type 2 Patients in Greece." Cost Eff Resour Alloc 2017.
Cita MLAKousoulakou, Hara, Magdalini Hatzikou, Varvara Baroutsou, and John Yfantopoulos. "Cost Effectiveness of Vildagliptin Versus Glimepiride As Add-on Treatment to Metformin for the Treatment of Diabetes Mellitus Type 2 Patients in Greece." Cost Eff Resour Alloc 2017.